Scleroderma drug trial shows up to 60% improvement
Drug Discovery World
NOVEMBER 30, 2023
The US Food and Drug Administration (FDA) recently granted Orphan Drug Designation for FT011 for the treatment of systemic sclerosis (scleroderma). The post Scleroderma drug trial shows up to 60% improvement appeared first on Drug Discovery World (DDW).
Let's personalize your content